DE69922819D1 - Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie - Google Patents
Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologieInfo
- Publication number
- DE69922819D1 DE69922819D1 DE69922819T DE69922819T DE69922819D1 DE 69922819 D1 DE69922819 D1 DE 69922819D1 DE 69922819 T DE69922819 T DE 69922819T DE 69922819 T DE69922819 T DE 69922819T DE 69922819 D1 DE69922819 D1 DE 69922819D1
- Authority
- DE
- Germany
- Prior art keywords
- striae
- dermatology
- prevention
- treatment
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010040925 Skin striae Diseases 0.000 title abstract 5
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000031439 Striae Distensae Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- -1 Lysine amino acids Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9812435A FR2784029B1 (fr) | 1998-10-05 | 1998-10-05 | Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie |
| FR9812435 | 1998-10-05 | ||
| PCT/FR1999/002375 WO2000019974A1 (fr) | 1998-10-05 | 1999-10-05 | Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69922819D1 true DE69922819D1 (de) | 2005-01-27 |
| DE69922819T2 DE69922819T2 (de) | 2005-12-22 |
Family
ID=9531192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69922819T Expired - Lifetime DE69922819T2 (de) | 1998-10-05 | 1999-10-05 | Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1119344B1 (de) |
| KR (1) | KR100568007B1 (de) |
| AT (1) | ATE285224T1 (de) |
| AU (1) | AU5989499A (de) |
| CA (1) | CA2346384C (de) |
| DE (1) | DE69922819T2 (de) |
| ES (1) | ES2234336T3 (de) |
| FR (1) | FR2784029B1 (de) |
| HK (1) | HK1039271A1 (de) |
| MX (1) | MXPA01003518A (de) |
| PL (1) | PL347095A1 (de) |
| PT (1) | PT1119344E (de) |
| WO (1) | WO2000019974A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2802413B1 (fr) * | 1999-12-17 | 2003-10-31 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause |
| FR2811892B1 (fr) * | 2000-07-18 | 2003-04-18 | Oreal | Composition comprenant un extrait de sophora japonica et utilisation |
| WO2002049656A1 (fr) | 2000-12-19 | 2002-06-27 | Kabushiki Kaisha Yakult Honsha | Preparations externes pour la peau et leur procede de production |
| FR2825918B1 (fr) * | 2001-06-14 | 2005-01-21 | Alfred Denner | Procede cosmetique du traitement des vergetures |
| FR2827170B1 (fr) | 2001-07-13 | 2004-07-16 | Soc Extraction Principes Actif | Utilisation de peptides pour augmenter l'adhesion cellulaire |
| ITMI20020147A1 (it) | 2002-01-29 | 2003-07-29 | Indena Spa | Estrazione purificazione e modificazione di polipeptidi da seme di soia |
| FR2856294B1 (fr) | 2003-06-18 | 2005-08-05 | Expanscience Lab | Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite |
| KR101045658B1 (ko) * | 2003-11-17 | 2011-07-01 | 쎄데르마 | 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물 |
| KR100656807B1 (ko) * | 2005-02-23 | 2006-12-13 | 배석년 | 구연산, 아연 및 아르기닌으로 이루어진 팽창선조 예방 및치료용 조성물 |
| JP2008074788A (ja) * | 2006-09-22 | 2008-04-03 | Rohto Pharmaceut Co Ltd | エラスチン産生促進剤 |
| KR100846356B1 (ko) * | 2007-11-27 | 2008-07-15 | 신라대학교 산학협력단 | 파래 속 추출물을 포함하는 항진균 조성물 |
| FR2938192B1 (fr) | 2008-11-07 | 2012-08-24 | Expanscience Lab | Nouvel actif anti-vergetures et compositions le comprenant |
| FR2939039B1 (fr) | 2008-12-01 | 2010-12-31 | Basf Beauty Care Solutions France Sas | Nouvel agent inhibiteur de secretion de sebum |
| FR2954702B1 (fr) | 2009-12-31 | 2013-07-05 | Basf Beauty Care Solutions F | Agent stimulant l'expression de loxl |
| FR2973246B1 (fr) | 2011-03-31 | 2013-04-12 | Nuxe Lab | Composition a base de camellia japonica pour la protection de la peau. |
| FR2977797B1 (fr) | 2011-07-13 | 2014-01-17 | Urgo Lab | Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures |
| FR2994387B1 (fr) | 2012-08-13 | 2016-07-29 | Basf Beauty Care Solutions France Sas | Ingredient hydratant cosmetique ou pharmaceutique |
| FR3003758B1 (fr) | 2013-03-27 | 2015-07-17 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique ou dermatologique d'un extrait de polygonum bistorta |
| FR3010314B1 (fr) | 2013-09-12 | 2017-05-05 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique ou dermatologique d'un extrait de tapirira guyanensis |
| FR3030275B1 (fr) | 2014-12-23 | 2018-03-02 | Basf Beauty Care Solutions France Sas | Utilisation d'un extrait de lythrum salicaria |
| FR3049859B1 (fr) | 2016-04-12 | 2023-11-03 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique d'un extrait de khaya senegalensis |
| FR3055799B1 (fr) | 2016-09-15 | 2020-06-19 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation cosmetique et/ou nutraceutique ou dermatologique d'un extrait de levure |
| FR3058641B1 (fr) | 2016-11-17 | 2019-11-01 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique, nutraceutique ou pharmaceutique preferentiellement dermatologique d'un extrait de feuilles de la plante lansium domesticum pour diminuer la pigmentation de la peau et/ou des annexes cutanees |
| FR3061015B1 (fr) | 2016-12-23 | 2019-09-20 | Basf Beauty Care Solutions France Sas | Utilisation cosmetique d'un extrait de corchorus olitorius |
| FR3065876B1 (fr) | 2017-05-05 | 2020-08-14 | Basf Beauty Care Solutions France Sas | Utilisation d'un extrait de nephelium lappaceum pour augmenter la fermete de la peau et/ou des muqueuses |
| FR3069162A1 (fr) | 2017-07-24 | 2019-01-25 | Basf Beauty Care Solutions France Sas | Extrait aqueux de momordica cochinchinensis pour maintenir et/ou augmenter l'expression des kindlines de la peau et des muqueuses |
| FR3097127B1 (fr) | 2017-10-03 | 2022-09-16 | Basf Beauty Care Solutions France Sas | Procédé d’utilisation d’un inhibiteur de Let-7b en cosmétique et/ou en nutraceutique |
| FR3071742B1 (fr) | 2017-10-03 | 2020-07-10 | Basf Beauty Care Solutions France Sas | Procede d'utilisation d'un inhibiteur de let-7b en cosmetique et/ou en nutraceutique |
| FR3082122B1 (fr) | 2018-06-11 | 2021-01-01 | Basf Beauty Care Solutions France Sas | Utilisation d'un extrait de bixa orellana |
| FR3085839A1 (fr) | 2018-09-13 | 2020-03-20 | Basf Beauty Care Solutions France Sas | Utilisation de phytosterols |
| FR3092493A1 (fr) | 2019-02-12 | 2020-08-14 | Dermaconcept Jmc | Composition cosmétique et/ou dermatologique pour lutter contre les vergetures |
| FR3093644B1 (fr) | 2019-03-12 | 2021-07-02 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation cosmétique de sphères poreuses d’oxyde métallique |
| FR3098405B1 (fr) | 2019-07-12 | 2021-06-25 | Expanscience Lab | Composition comprenant des polyphénols de graines de passiflore, des peptides d’avocat et un extrait d’hamamélis et utilisation pour traiter et/ou prévenir les vergetures |
| FR3099702B1 (fr) | 2019-08-08 | 2022-03-25 | BASF Beauty Care Solutions FR | Nouvelle utilisation cosmétique d’un extrait d’Epilobium angustifolium |
| FR3099701B1 (fr) | 2019-08-08 | 2022-03-25 | BASF Beauty Care Solutions FR | Nouvelle utilisation cosmétique d’une combinaison d’oenothéine-B et de quercétine-3-O-glucuronide |
| FR3125967A1 (fr) | 2021-08-06 | 2023-02-10 | Basf Beauty Care Solutions France Sas | Utilisations cosmétiques contre la lumière bleue de microsphères poreuses d’oxyde métallique |
| FR3131838A1 (fr) | 2022-01-18 | 2023-07-21 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation cosmétique de sphères poreuses à porosité fermée d’oxyde métallique |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5444091A (en) * | 1994-05-24 | 1995-08-22 | Dermatology Home Products, Inc. | Method of applying alpha hydroxy acids for treating striae distensae |
| US5759555A (en) * | 1996-06-07 | 1998-06-02 | Moy; Lawrence S. | Cosmetic formulation and method for amelioration of skin keratoses and striae distensae |
-
1998
- 1998-10-05 FR FR9812435A patent/FR2784029B1/fr not_active Expired - Lifetime
-
1999
- 1999-10-05 KR KR1020017004297A patent/KR100568007B1/ko not_active IP Right Cessation
- 1999-10-05 AT AT99970017T patent/ATE285224T1/de not_active IP Right Cessation
- 1999-10-05 PT PT99970017T patent/PT1119344E/pt unknown
- 1999-10-05 EP EP99970017A patent/EP1119344B1/de not_active Expired - Lifetime
- 1999-10-05 DE DE69922819T patent/DE69922819T2/de not_active Expired - Lifetime
- 1999-10-05 CA CA2346384A patent/CA2346384C/fr not_active Expired - Fee Related
- 1999-10-05 WO PCT/FR1999/002375 patent/WO2000019974A1/fr active IP Right Grant
- 1999-10-05 AU AU59894/99A patent/AU5989499A/en not_active Abandoned
- 1999-10-05 PL PL99347095A patent/PL347095A1/xx not_active Application Discontinuation
- 1999-10-05 ES ES99970017T patent/ES2234336T3/es not_active Expired - Lifetime
- 1999-10-05 MX MXPA01003518A patent/MXPA01003518A/es not_active IP Right Cessation
-
2001
- 2001-11-30 HK HK01108460A patent/HK1039271A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100568007B1 (ko) | 2006-04-07 |
| MXPA01003518A (es) | 2002-09-18 |
| CA2346384A1 (fr) | 2000-04-13 |
| AU5989499A (en) | 2000-04-26 |
| PL347095A1 (en) | 2002-03-25 |
| CA2346384C (fr) | 2011-07-12 |
| ATE285224T1 (de) | 2005-01-15 |
| ES2234336T3 (es) | 2005-06-16 |
| PT1119344E (pt) | 2005-05-31 |
| EP1119344B1 (de) | 2004-12-22 |
| WO2000019974A1 (fr) | 2000-04-13 |
| FR2784029A1 (fr) | 2000-04-07 |
| EP1119344A1 (de) | 2001-08-01 |
| DE69922819T2 (de) | 2005-12-22 |
| KR20010079997A (ko) | 2001-08-22 |
| HK1039271A1 (en) | 2002-04-19 |
| FR2784029B1 (fr) | 2001-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69922819D1 (de) | Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie | |
| DE69835279D1 (de) | Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika | |
| BR0210282A (pt) | Veìculos de distribuição de fosfato de cálcio para proteìnas osteoindutivas | |
| BRPI0213786B8 (pt) | peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
| DE693928T1 (de) | Aminozucker- und glykosaminoglykanzusammensetzung zur behandlung und reparatus von bindegewebe | |
| HUP9904023A2 (hu) | Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban | |
| ATE275383T1 (de) | Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen | |
| ATE284959T1 (de) | Unterbrechung der bindung der proteine mdm2 und p53 und entsprechende therapeutische anwendung | |
| ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
| MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
| WO2003008443A3 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
| DE69703689T2 (de) | Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia | |
| AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
| DE60031951D1 (de) | Methoden zur verwendung von neurotrophin 3 (nt-3) zur behandlung von gastrointestinalen hypomobilitätsstörungen | |
| DE69902520D1 (de) | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden | |
| ATE409492T1 (de) | Zusammensetzung zur vermeidung und behandlung von cellulitis | |
| DE69818823D1 (de) | Dipohosphonsäuresalze für die behandlung von osteoporose | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| ATE336992T1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz- erkrankungen | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| DE69827387D1 (de) | Verwendung von pramipexol zur behandlung von restless-legs-syndrom | |
| ID23184A (id) | Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi | |
| ID19618A (id) | Komposisi komposisi asam amino dan pemakaiannya dalam makanan untuk pengobatan | |
| NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
| DE69725434D1 (de) | Zusammensetzung zur behandlung von kontaktlinsen und methode zur anwendung derselben |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |